Navigation Links
Clinilabs Welcomes Anesthesiologist Dr. Admir Hadzic Who Will Provide CSF/cCSF Capabilities For Clinilabs
Date:4/30/2013

NEW YORK, April 30, 2013 /PRNewswire-iReach/ -- Clinilabs, an early phase and specialty CRO that provides clinical drug development services to industry, today announced the arrival of Dr. Admir Hadzic to the Clinilabs team.  Dr. Hadzic will provide expertise in the development of drugs to treat pain, and also will manage the collection of CSF/cCSF samples in clinical trials.

Dr. Admir Hadzic has been at the forefront of academic anesthesiology for nearly two decades. His work has substantially contributed to the development of functional regional anesthesia anatomy, standardized techniques of nerve blocks, patient outcome benefits of regional anesthesia, and monitoring principles to standardize the practice and decrease the risk of complications of nerve blocks.  He has published numerous peer-reviewed articles and two leading textbooks, and is a founder of the global educational programs Networking World Anesthesia Convention and the New York School of Regional Anesthesia. Through these educational programs, Dr. Hadzic has trained physicians Worldwide in anesthesia techniques and other procedures such as CSF sampling. 

Dr. Gary Zammit , President and CEO of Clinilabs, states "Clinilabs is pleased to welcome Dr. Hadzic to our team.  He is a leader in the field of anesthesia who significantly broadens the capabilities we are able to offer our clients.  We look forward to his consultancy on multicenter pain trials that we manage, as well as his hands-on contribution to the trials being conducted at our NYC and NJ Phase I units that require anesthesia services." 

About Clinilabs Inc.

Clinilabs is a full-service contract research organization (CRO) that specializes in early-phase studies, from first-in-human to proof-of-concept, with normal healthy volunteers and patient populations.  The company owns and operates two Phase I units in the US, and maintains a network of highly qualified investigator sites for multicenter Phase II studies Worldwide.  Specialty projects, including pharmacodynamic, biomarker, cardiac safety, sleep/wakefulness, metabolic, and Japanese bridging are among our strengths.  Clinilabs is recognized globally as a leading specialty CRO, offering an alternative to large CROs for specialty projects.  For more information, please visit www.clinilabs.com.

Media Contact: Hannah DAoust , Clinilabs, 646-215-6480, hdaoust@clinilabs.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Clinilabs
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. EMBO welcomes 55 leading life scientists as members
2. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisor Board
3. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisory Board
4. The CNIO welcomes the new academic year with a spotlight on cancer genetics
5. Chiltern Welcomes Cedric Burg And James Gunter
6. Mayo Clinic anesthesiologist earns APSs Walter B. Cannon Award
7. Reproductive health providers should discuss environmental exposure risks with patients
8. Research on flavanols and procyanidins provides new insights into how these phytonutrients may positively impact human health
9. Artificial wetlands can provide benefits over the long haul
10. Discovery provides blueprint for new drugs that can inhibit hepatitis C virus
11. Heightened Security Threats and Economic Issues Provide Fillip to Global Civil and Military Biometrics Market, Says Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 2017 Optimove , provider of ... such as 1-800-Flowers and AdoreMe, today announced two ... Replenishment. Using Optimove,s machine learning algorithms, these features ... replenishment recommendations to their customers based not just ... customer intent drawn from a complex web of ...
(Date:3/20/2017)... Germany , March 20, 2017 At this ... Hamburg -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG ... is this year,s CeBIT partner country. At the largest German ... biometrics in use: fingerprint, face and iris recognition as well as DERMALOG´s ... ...
(Date:3/16/2017)... , March 16, 2017 CeBIT 2017 - Against identity fraud ... Continue Reading ... Used combined in one project, multi-biometric solutions provide a ... Used combined ... ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... ... April 20, 2017 , ... As part ... will explore challenging patient cases when screening for direct oral anticoagulant. When patients ... a need for bridging parental anticoagulation especially for those at high risk of ...
(Date:4/20/2017)... ... ... NetDimensions appoints Bill Mastin, a learning technology veteran, as its new Senior ... learning technologies industry, Mastin joins NetDimensions from the New York office of learning and ... Mastin served as SVP of the North America offices and prior to that, he ...
(Date:4/20/2017)... 2017 Dutch philosopher Koert van Mensvoort - founder ... University of Technology in Eindhoven - has written a ,Letter to Humanity, ... on humanity to avoid becoming a slave and victim to its own technology, ... ... Dutch philosopher Koert van Mensvoort – founder of the Next Nature Network and ...
(Date:4/19/2017)... ... 18, 2017 , ... Alisa Wright, founder and CEO of Singota Solutions ... of Pharmacy in Lafayette, Indiana. , The Distinguished Alumni Award was established in ... and other scientific endeavors. , Wright began her career in the pharmaceutical industry ...
Breaking Biology Technology: